↓ Skip to main content

Abstract A089: NST-628 is a potent, fully brain-penetrant, RAS/MAPK pathway molecular glue inhibitor with efficacy in CNS tumor models

Overview of attention for article published in Molecular Cancer Therapeutics, December 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

1 X user

Readers on

1 Mendeley